These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31477374)

  • 21. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability.
    Xu H; Kellendonk CB; Simpson EH; Keilp JG; Bruder GE; Polan HJ; Kandel ER; Gilliam TC
    Schizophr Res; 2007 Feb; 90(1-3):104-7. PubMed ID: 17113268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia gene discovery.
    Harv Ment Health Lett; 2002 Mar; 18(9):7-8. PubMed ID: 11916647
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco.
    Nawaz R; Siddiqui S
    CNS Neurol Disord Drug Targets; 2015; 14(8):1086-95. PubMed ID: 25801838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
    Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population.
    Yang B; Niu W; Chen S; Xu F; Li X; Wu X; Cao Y; Zhang R; Yang F; Wang L; Li W; Xu Y; He L; He G
    Psychiatry Res; 2016 Nov; 245():361-364. PubMed ID: 27591410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders.
    Xu Q; Jia YB; Zhang BY; Zou K; Tao YB; Wang YP; Qiang BQ; Wu GY; Shen Y; Ji HK; Huang Y; Sun XQ; Ji L; Li YD; Yuan YB; Shu L; Yu X; Shen YC; Yu YQ; Ju GZ;
    Mol Psychiatry; 2004 May; 9(5):510-21. PubMed ID: 14745454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia.
    Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR
    Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.
    Bortolato M; Walss-Bass C; Thompson PM; Moskovitz J
    World J Biol Psychiatry; 2017 Apr; 18(3):247-254. PubMed ID: 27458023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An association study of COMT gene polymorphisms with schizophrenia].
    KONG FZ; PENG ZZ; JIANG TY; HONG XH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):208-11. PubMed ID: 21462137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees.
    Grassi E; Mortilla M; Amaducci L; Pallanti S; Pazzagli A; Galassi F; Guarnieri BM; Petruzzi C; Bolino F; Ortenzi L; Nistico R; De Cataldo S; Rossi A; Sorbi S
    Neurosci Lett; 1996 Mar; 206(2-3):196-8. PubMed ID: 8710185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.
    Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of schizophrenia: past, present and future.
    Prasad S; Semwal P; Deshpande S; Bhatia T; Nimgaonkar VL; Thelma BK
    J Biosci; 2002 Feb; 27(1 Suppl 1):35-52. PubMed ID: 11927776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
    Eisenstein SA; Bogdan R; Chen L; Moerlein SM; Black KJ; Perlmutter JS; Hershey T; Barch DM
    J Psychiatr Res; 2017 Mar; 86():9-17. PubMed ID: 27886638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of genetic variants of the dopaminergic system in heroin dependence].
    Vereczkei A; Sasvári-Székely M; Barta C
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):95-101. PubMed ID: 19827317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of the genetics of substance use disorders.
    Lachman HM
    Curr Psychiatry Rep; 2006 Apr; 8(2):133-43. PubMed ID: 16539891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aki H; Sumitani S; Itakura M; Ohmori T
    J Neural Transm (Vienna); 2007 Feb; 114(2):255-9. PubMed ID: 16897602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between two dopamine D2 receptor gene polymorphisms and schizophrenia.
    Caprini S; Saetre P; Melle I; Djurovic S; Andreassen OA; Skjødt C; Duong L; Werge T; Hall H; Agartz I; Terenius L; Jönsson EG
    Psychiatr Genet; 2011 Aug; 21(4):214-5. PubMed ID: 21712758
    [No Abstract]   [Full Text] [Related]  

  • 38. Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.
    Perlman WR; Weickert CS; Akil M; Kleinman JE
    J Psychiatry Neurosci; 2004 Jul; 29(4):287-93. PubMed ID: 15309045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.
    Hirvonen J; van Erp TG; Huttunen J; Aalto S; Någren K; Huttunen M; Lönnqvist J; Kaprio J; Hietala J; Cannon TD
    Arch Gen Psychiatry; 2005 Apr; 62(4):371-8. PubMed ID: 15809404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.
    Schellekens AF; Franke B; Ellenbroek B; Cools A; de Jong CA; Buitelaar JK; Verkes RJ
    Addict Biol; 2013 Mar; 18(2):344-56. PubMed ID: 22509987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.